NCT02438267

Brief Summary

Nephrocalcinosis (NC), defined as calcification of renal tissue, has been reported to occur in 7-41% of premature infants. Causes of NC are likely multi-factorial, and infants born prematurely and with very low birth weight (\<1500 gm) seem to be at the highest risk of developing NC. Recent changes in recommendations for nutrition for the preterm infant such as higher intakes of protein, calcium, and vitamin D may also play a factor in the pathogenesis of NC. Currently, diagnosis of NC often occurs incidentally during ultrasound evaluation for other issues. Because there is no acute symptom or pattern of symptoms in the preterm population associated specifically with NC, it is possible that many cases of NC may not be diagnosed. Presently, it is impractical and costly to screen all infants for NC with renal ultrasound, therefore there is no standard of care regarding screening for NC. NC may have long-term effects. Studies have shown that preterm infants with NC had shorter kidneys and a lower rate of tubule resorption of phosphorus (TRP) than preterm infants without NC. This study will analyze weekly urinalysis for all enrolled subjects prospectively and then look at the incidence of NC at discharge of the enrolled subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 1, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 8, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

March 13, 2017

Status Verified

June 1, 2016

Enrollment Period

1.8 years

First QC Date

May 1, 2015

Last Update Submit

March 9, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Urinary calcium to creatinine ratio (UCa/Cr)

    Beginning within the first two weeks of life, urine calcium to creatinine ratio (UCa/Cr) will be analyzed weekly through discharge and then correlated to renal ultrasound results done prior to discharge.

    3 months

  • Urinary crystals

    Beginning within the first two weeks of life, urinalysis for evidence of urinary crystallization will be analyzed weekly through discharge and then correlated to renal ultrasound results done prior to discharge.

    3 months

Secondary Outcomes (6)

  • Serum Vitamin D levels

    3 months

  • Vitamin D intake

    3 months

  • Calcium intake

    3 months

  • Protein intake

    3 months

  • Total bone density per DXA

    3 months

  • +1 more secondary outcomes

Study Arms (2)

Non-NC group

Enrolled subjects who did not have evidence of NC on renal ultrasound

NC group

Enrolled subjects who did have evidence of NC on renal ultrasound

Eligibility Criteria

AgeUp to 2 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Infants admitted to the newborn intensive care unit.

You may qualify if:

  • Infants whose gestation less than or equal to 32 weeks and/or birth weights less than 1800 gm

You may not qualify if:

  • Infants with congenital abnormalities of the heart, lung, GI, or kidneys that will affect renal function.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Intermountain Medical Center

Murray, Utah, 84157, United States

Location

MeSH Terms

Conditions

Premature BirthNephrocalcinosisHypercalciuria

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesMale Urogenital DiseasesCalcinosisCalcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Sabrina Malone-Jenkins, MD

    University of Utah

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2015

First Posted

May 8, 2015

Study Start

April 1, 2015

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

March 13, 2017

Record last verified: 2016-06

Locations